Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 47 citing articles:

Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
Emily A. Holmes, Rory C. O’Connor, V. Hugh Perry, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 6, pp. 547-560
Open Access | Times Cited: 5665
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta, Devesh Srivastava, Mehar Sahu, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1315-1360
Open Access | Times Cited: 919
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola, et al.
Travel Medicine and Infectious Disease (2020) Vol. 34, pp. 101663-101663
Open Access | Times Cited: 765
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
Christian Devaux, Jean‐Marc Rolain, Didier Raoult
Journal of Microbiology Immunology and Infection (2020) Vol. 53, Iss. 3, pp. 425-435
Open Access | Times Cited: 477
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
Julien Andréani, Marion Le Bideau, Isabelle Duflot, et al.
Microbial Pathogenesis (2020) Vol. 145, pp. 104228-104228
Open Access | Times Cited: 305
Azithromycin in viral infections
Madeleine Oliver, Timothy S.C. Hinks
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 146
A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants
Johnson Olaleye Oladele, Ebenezer I. O. Ajayi, Oyedotun M. Oyeleke, et al.
Heliyon (2020) Vol. 6, Iss. 9, pp. e04897-e04897
Open Access | Times Cited: 91
Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway
Shahla Shojaei, Madhumita Suresh, Daniel J. Klionsky, et al.
Virulence (2020) Vol. 11, Iss. 1, pp. 805-810
Open Access | Times Cited: 85
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione
Desirée Bartolini, Anna Maria Stabile, Sabrina Bastianelli, et al.
Redox Biology (2021) Vol. 45, pp. 102041-102041
Open Access | Times Cited: 76
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
Zahra Molavi, Sara Razi, Seyed Amir Mirmotalebisohi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111544-111544
Open Access | Times Cited: 64
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
Brianna J. Stubbs, Andrew P. Koutnik, Emily L. Goldberg, et al.
Med (2020) Vol. 1, Iss. 1, pp. 43-65
Open Access | Times Cited: 60
Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111330-111330
Open Access | Times Cited: 46
The role of autophagy in controlling SARS‐CoV‐2 infection: An overview on virophagy‐mediated molecular drug targets
Saman Sargazi, Roghayeh Sheervalilou, Mohsen Rokni, et al.
Cell Biology International (2021) Vol. 45, Iss. 8, pp. 1599-1612
Open Access | Times Cited: 42
Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection
Hanan Polansky, Gillad Lori
International Journal of Antimicrobial Agents (2020) Vol. 55, Iss. 6, pp. 105971-105971
Open Access | Times Cited: 40
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
Yash Gupta, Dawid Maciorowski, Samantha E. Zak, et al.
Methods (2021) Vol. 195, pp. 57-71
Open Access | Times Cited: 34
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
Sarah Aherfi, Bruno Pradines, Christian Devaux, et al.
Future Microbiology (2021) Vol. 16, Iss. 17, pp. 1341-1370
Open Access | Times Cited: 34
Immunopharmacological perspective on zinc in SARS-CoV-2 infection
Sima Heydarzadeh Asl, Sepideh Nikfarjam, Naime Majidi Zolbanin, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107630-107630
Open Access | Times Cited: 30
Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses
Morvarid Siri, Sanaz Dastghaib, Mozhdeh Zamani, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5992-5992
Open Access | Times Cited: 30
A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase
Suliman Khan, Farnoosh Attar, Samir Haj Bloukh, et al.
International Journal of Biological Macromolecules (2021) Vol. 181, pp. 605-611
Open Access | Times Cited: 27
Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
Shukur Wasman Smail, Muhammad Saeed, Twana Alkasalias, et al.
Food and Chemical Toxicology (2021) Vol. 150, pp. 112087-112087
Open Access | Times Cited: 24
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial
Timothy S.C. Hinks, Vicki Barber, Joanna Black, et al.
Trials (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?
Şeyma Taştemur, Hilmi Ataseven
Medical Hypotheses (2020) Vol. 143, pp. 110018-110018
Open Access | Times Cited: 24
Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19
Diogo de Moraes, Brunno Vivone Buquete Paiva, Sarah Santiloni Cury, et al.
Aging and Disease (2021) Vol. 12, Iss. 1, pp. 42-42
Open Access | Times Cited: 19
Autophagy and SARS-CoV-2-Old Players in New Games
Tsvetomira Ivanova, Yuliia Mariienko, Nikolay Mehterov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7734-7734
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top